Expanding ecosystem of health-related data has led to opening of greater opportunities for the healthcare industry to get the right treatment to the right patient. There is growing emphasis on generating and using Real World Data (RWD) to evaluate continued safety and effectiveness of products.
FDA defines RWE as the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of real-world data (RWD). RWD are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources.
While clinical trial data provides the basis for drug approval, it doesn’t cover all aspects from the real world due to its homogenous patient groups defined by inclusion/exclusion criteria and its fixed setting as per the study protocol. RWE helps bridge the gap between research and everyday practice in healthcare. It serves the following uses:
EMR is not designed to be shared outside the individual practice and is mainly used by providers for diagnosis and treatment. On the other hand, EHR allows patient data to move with them and can be shared between providers, labs, etc and can be used as a tool by providers to make decisions since it holds real time information.
Actu-Real offers solutions and services to help payers, providers and pharmaceutical companies optimize objectives of access, quality and cost of healthcare, with the backbone of a fit-for-purpose, all-in-one technology platform for data integration, advanced analytics, reporting and visualization.